Evaluation of the Effect of Alkaloid Berberine on the Positive and Negative Symptoms of the Patients with Schizophrenia: A Double-Blind Randomized Placebo-Controlled Clinical Trial

• Principais autores: Ebrahim Moghimi Sarani (Autor), Fatemeh Ghorbannezhad (Autor), Mohammad Hassan Meshkibaf (Autor), Marjan Shakibaee (Autor), Seyed Hamdollah Mosavat (Autor)
• Formato: Livro
• Publicado em: Tehran University of Medical Sciences, 2022-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Schizophrenia is a severe psychiatric condition that affects approximately 1% of the global population. Over the last decade, the efficacy of berberine as a complementary therapy in psychiatric diseases without significant side effects has been demonstrated. Therefore, this study assessed the effect...